论文 · 队列研究
C反应蛋白变化可预测嵌合抗原受体T细胞治疗后的感染风险
Changes in C-Reactive Protein Forecast Infection Risk Following Treatment with Chimeric Antigen Receptor T Cells
作者:Poonam Mathur, Hegang Chen, David J Riedel, Elizabeth Holland, Danica Palacio, Jacqueline T Bork, Katya Prakash, Nancy Hardy, Mehmet Kocoglu, Ashraf Badros, Ariel Fromowitz, Jean Yared 等 15 人
Cancers (Basel) · 2026年9月9日 · Mathur 等 15 位作者
不需要生物学背景,多打比方
正在获取全文并生成讲解(拿不到全文就依据摘要)…
已等待 0 秒大约需要 10–20 秒
可以先看别的,做好了会自动出现在这里。
这篇还没有动画
动画会把研究的流程、作用机制和关键结果一步一步演示出来,每一步都标明出自原文哪里。制作大约需要一两分钟。
摘要Abstract
BACKGROUND: Immunosuppressive conditioning regimens for chimeric antigen receptor-modified T cell immunotherapy (CARTx) and subsequent T cell dysfunction increase risk for infection. However, it is difficult to discern infection from CRS in the early (up to Day 30) and late (Days 31-180) periods after CARTx due to overlapping signs and symptoms.
METHODS: We analyzed infectious complications and predictors of infection during the early and late periods after CARTx in 213 adult patients with malignancies over a 5-year period.
RESULTS: Overall, 75 patients (35%) had at least one infection, mostly within the first 30 days after CARTx. Infections occurring early after CARTx were mostly bacterial, whereas viral infections predominated after Day 30. In multivariate analyses, a high baseline CRP (≥5 mg/dL) was significantly associated with increased risk of infection in the early period after CARTx, and a Day-5-to-baseline-CRP ratio of <1.5 was significantly associated with a higher risk of infection through all 180 days after CARTx and during the late period after CARTx.
CONCLUSIONS: Infections in adult patients are common up to 180 days after receiving CARTx. High baseline CRP without significant temporal changes may predict risk of infection. Tracking CRP trends may be a useful clinical tool for discerning causes of fever and guiding antibiotic stewardship in this population at high risk for infections.
还没有查过关联研究
我会去找这篇研究之前的基础工作、做类似事情的研究,以及之后引用它的研究,并说明每篇为什么相关。